62 replies to this topic

[Gerald W. Gaston]

Another place it is being discussed:

http://www.forums.ab...highlight=gcmaf

[Morgain]

Hopefully I am posting this correctly.

I would appreciate any info that could guide me to find immediate treatment with Gc-MAF. Is there a name and contact number for a person organizing the clinical trial in the bahamas? The website link is unclear.

My email is magdalena99@earthlink.net.

Any ideas or thought/feedback eagerly awaited.

Thank You.

The website of the IAT clinic in freeport Bahama's can be found at: http://www.immunemedicine.com

More information about GcMaf at: http://immunemedicin...herapies/gcmaf/

Contact details at: http://immunemedicine.com/contact-us/

IAT

East Atlantic Drive
Freeport
Grand Bahama
Bahamas

Postal Address
P.O. Box F-42689
Freeport
Grand Bahama
Bahamas

Phone: (242) 352-7455
Fax: (242) 352-3201
mail@immunemedicine.com

If there are any patients that have tried this GcMAF therapy at the IAT clinic in freeport or anywhere else, please share your experiences here in this thread!

I would also like to know if the IAT clinic really has approval from Dr Yamamoto to do trial tests.

Edited by Morgain, 23 June 2010 - 02:52 PM.

[medicineman]

this seems like its too good..... Please, if anyone is able to find a source for this, it would be highly appreciated. This gives me a glimmer of hope for the future

[ppp]

this seems like its too good..... Please, if anyone is able to find a source for this, it would be highly appreciated. This gives me a glimmer of hope for the future

Take a look here: http://www.gcmaf.eu/info/

[Ark]

May 31, 2008

Dear Shylock,

We have exhausted GcMAF stock. We hope to prepare new stock of GcMAF in a few months. We keep your information until approval for commercialization of GcMAF. However, our institute is non-profit organization and we can collaborate with your group for cancer therapy.

Incidentally GcMAF is the most powerful curative remedy for HIV disease. We are glad to help you for GcMAF therapy of tuberculosis and hepatitis.

Regards,

Dr. Nobuto Yamamoto, Director

Socrates Institute for Therapeutic Immunology

-------------------------------------------------
That's all I've gotten out of him. I'm prepared to put this stuff to work today. He just hasn't given any indication that he will sell it to me or license the technology.

P.S. I'm outside the USA so the FDA is not a concern for me. I'm ready to roll with the discovery, but except for the above e-mail I haven't gotten any other response from him. This discovery, if true, is a potential gold mine. Anyone want to figure out how to extract Gc-MAF? I'm open to other suppliers.

Hi you mention Tubuculousis being one of the many things Cc-MAF can treat, I have a really bad tropiconal lung infection a strain of t.b that i can't seem to get rid of and currently my left lung is halfway consumed with fluid. How much would a full treatment cost, I'd really like to be rid of my problem 3 half years going.

Edited by Ark, 12 July 2010 - 05:37 PM.

[jondoeuk]

Safety Study of GcMAF (Globulin Component Macrophage Activating Factor) in Subjects With Advanced Solid Tumors https://clinicaltria...how/NCT02052492

 

Cancer treatment developer Efranat raises $4.5m http://www.globes.co...lion-1000987334

 

 

Canines Treatment Results

Efranat conducted compassionate, pre-clinical treatments of spontaneous cancer in canines at The Koret School of Veterinary Medicine, Hebrew University of Jerusalem (Beit Dagan). The research was approved by an ethics committee and Efranat received full consent from the canines’ owners. The participating canines had life expectancies of a few months.

The study was led by Dr. Gillian Dank, a canine oncologist. All dogs underwent a variety of conventional therapies, such as tumor resection and chemotherapy, prior to initiating the GcMAF therapy. The recruited dogs were non-responsive or stopped responding to standard treatment.

14 canines were treated with GcMAF - SC injection at a dose of 0.5-1 ml/70 kg (200ng/ml GcMAF) once a week.


One example:

Complete response of canine with recurring T cell cutaneous lymphoma, progress during GcMAF therapy

 

 

Summary of the Results:

2/14 canines were fully recovered
7/14 canines responded to the treatment - partial response1 or stable disease2
5/14 canines did not respond to the treatment. Those 4 canines had progressive disease3 and died 4-6 weeks from the beginning of treatment


1) Partial response = >50% but <100% decrease in tumor size

2) Stable disease = tumor volume did not decrease by >50% or increase by >25%

3) Progressive disease = an increase in tumor volume of >25% or the appearance of new neoplastic lesions



Having received promising results from this study and other studies, Efranat has taken steps towards Phase 1 studies in cooperation with a leading medical center in Israel. The Company has also applied to the relevant regulatory authorities.

 

http://efranat.com/

 

[jondoeuk]

Indications for GcMAF for immunotherapy of cancers and chronic viral and bacterial infections http://www.saisei-mi...toshio-inui.pdf

 

Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy http://www.saisei-mi...mic-therapy.pdf

 

http://www.saisei-mi.../index_eng.html

[jondoeuk]

Phase I Dose Escalation completion


Phase I Dose Escalation in 12 patients with solid tumors has been successfully completed with promising results MTD has not been reached. Treatment was well tolerated with only mild adverse effects mainly flu like symptoms and rash. Interesting pharmacodynamics findings were observed and will be further investigated in the next part of the study. The Dose Expansion part of the study will begin on August 2015 and will include additional 24 patients.

 

http://efranat.com/News-Events.aspx

[Grim Reaper]

Several doctors researching GcMAF have end up taking dirt naps.

[niner]

Several doctors researching GcMAF have end up taking dirt naps.

 

Are you implying that these doctors have been killed by, um, some evil entity? 

[Grim Reaper]

Evil entity.   ​I'm sure it is just a coincidence. Probably all committed suicide with a blunt object.​ I can't post links yet. Google "GcMAF dead doctors" and you will find some links.

[Grim Reaper]

I truely admire the efforts of these doctors to help others!

[Grim Reaper]

Anyone have any comments on GcMaf yogurt? Like Bravousa stuff?

[Grim Reaper]

We need to get this figured out cause I'm looking forward to a long needed vacation!

[zorba990]

Anyone have any comments on GcMaf yogurt? Like Bravousa stuff?

Google brings up many, very dubious looking websites, with outrageous prices for these probiotics.
Exactly the kind of thing that red-flags something for governng bodies to whine about.
Reminds me of the igrowhair telomerase guy and his telomerase yogurt (for your head)
So looks, on the surface, like a quick money grab. But would certainly like to hear more.

[Grim Reaper]

Yes, I have been trying to find untainted information, that is the problem.

 

[zorba990]

Yes, I have been trying to find untainted information, that is the problem.

https://www.youtube....1&v=KqMohmjJ4mg

The press is after him
http://guernseypress...illion-a-month/

[Grim Reaper]

I don't think anyone has posted this yet. The last half looks interesting.

 

 

 

[zorba990]

Hard to know what to beleive. Now I read claims here that Nagalase is in vaccines
http://www.naturalne...ry_profits.html
http://everydayconce...se-in-vaccines/

Edited by zorba990, 21 September 2015 - 02:48 AM.

[Grim Reaper]

Shuush!!!! That must be discredited immediately! Don't tell California.

Edited by Grim Reaper, 21 September 2015 - 02:54 AM.

[zorba990]

Only $150/month oh boy....
http://www.marsvenus...robiotic-yogurt

[Grim Reaper]

Dammit, every time I buy something it always shows up cheaper somewhere else... :( 

Call me racist but I really don't trust Martians or Venetians.

[niner]

Hard to know what to beleive. Now I read claims here that Nagalase is in vaccines
http://www.naturalne...ry_profits.html
http://everydayconce...se-in-vaccines/

 

It's not that hard.  If you read it on NaturalNews, it's probably BS.  The other site is even crazier than NN.

[Grim Reaper]

My yogurt stuff will be here tomorrow. I will let you know if I die.......

[resveratrol_guy]

Dr. Yamamoto's GcMAF paper was retracted according to Retraction Watch. It sounds like the main reasons were the use of invalid cancer staging metrics and evidence of forged endorsements.

 

Having said that, the involvement of a quack scientist does not imply that the GcMAF story is false. We'll have to wait for trials like this one to shed more light on the substance.

 

In the meantime, I think the central question is really whether or not GcMAF can result in the destruction of cancer stem cells, which is a hard requirement for any purported cancer cure. Chemotherapy can already shrink tumors with high probability, buying precious time for patients. If GcMAF can do the same with fewer side effects, I'm all for it. But unless it anihilates the stem cells as well, it's not a cure. If the dog data above is informative, then perhaps it can actually do so under certain unknown circumstances.

 

If I had cancer, I'd probably take GcMAF with 3-bromopyruvate, while carefully monitoring for tumor lysis syndrome.

 

[Logic]

There's a lot of BS to sift through when researching this.
I wouldn't normally post this link to this nagalase reducing yogurt, but there seems to be some anecdotal evidence that it works.  See post #20 etc. in the bottom link.

https://bisforbanana...peter-trayhurn/

 

http://forums.phoeni...immunity.27288/

[nicklesprout]

has anyone seen this?

 

http://www.autismone...ctrum-disorders

 

bravo yogurt, ketogenic diet for autism, etc. cure..

[LaViidaLocaa]

has anyone seen this?

 

http://www.autismone...ctrum-disorders

 

bravo yogurt, ketogenic diet for autism, etc. cure..

 

Though out of the scope of this topic, seems interesting. Pretty pricey though and alas no honest reviews to be found it seems..

[jondoeuk]

A phase 1 open label, dose-escalation trial evaluating the safety and tolerability of EF-022, macrophage activator, in subjects with advanced solid malignancies http://www.abstracts...6c-deae12e60491

[zorba990]

Info from Jappanese company producing this::
http://www.saisei-mi...ophage_eng.html



New research papers on Oral Colostrum GcMAF for Chronic Fatigue Syndrome (CFS) and serious infection published in Anticancer Research journal.

Research paper
2015 Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports (PDF)
Anticancer Res August 2015 35 (8) 4545-4549

Background

GcMAF (Gc Protein derived Macrophage Activating Factor) occurs naturally in our bodies and activates macrophages to destroy cancerous cells and foreign invaders such as bacteria and viruses. Serious illnesses like cancer, HIV and viral hepatitis destroy GcMAF and so neutralizes our immune system to defend itself. This allows the disease to progress uncontrolled.

We use a small sample of serum from healthy human people to produce large amounts of new second generation GcMAF in our specialized sterile laboratory called a Cell Processing Center (CPC). This highly active Second Generation Gc-MAF is injected intramuscularly (IM) or subcutaneously (SC) into the patient usually twice weekly, and in some cases 3 times weekly. Over a matter of weeks and months the immune system becomes strengthened through the activation of macrophages, and begins to eradicate cancer cells, viruses and bacteria. In addition to GcMAF injections, another form of GcMAF manufactured from high quality colostrum can be administered orally in the gut and sublingually in the mouth to activate macrophages in the lymphoid tissue.

General goals of GcMAF therapy are to:

Improve well-being and quality of life (QOL)
Return the patient to good health so that they are able to participate in regular lifestyle activities
Achieve long term survival
Enhance the effect of other therapies
Repair the immune system
Increase the number of monocytes (macrophages) and activate them to destroy cancer cells, viruses, bacteria and other pathogens in the body
Increase the rate of maturation of dendritic cells (DCs)
GcMAF therapy overview

One course of High Dose GcMAF is usually 48 doses for 6 months (2 times weekly administration).
For advanced disease, High Dose GcMAF may be administered 3 times weekly.
Additional courses may be required depending on stage of disease and other factors specific to each patient.
Treatment should be continued at the high dose as long as necessary while disease is present to destroy cancer cells, viruses, bacteria and other pathogens in the body.
For serious diseases we recommend a combination of GcMAF injection and daily Colostrum MAF by oral and sublingual administration for the most effective treatment.
Longer term maintenance doses of High Dose GcMAF may be important to reduce recurrence after all evidence of disease eradication.
Oral Colostrum MAF may be a convenient long term option to maintain health.
Other important points

Activating macrophages with High Dose GcMAF is an important part of any treatment program which can be used alone or in combination with most other therapies.
GcMAF works especially well in synergy with targeted therapies which don't harm the immune system. Examples of targeted therapies include hormone therapies, monoclonal antibody drugs, small-molecule drugs, signal transduction inhibitors (HER2 inhibitors, BRAF inhibitors, EGFR inhibitors), angiogenesis inhibitors, immunotherapy drugs (such as drugs that target CTLA-4 protein).
Second Generation GcMAF has the advantage of having no side effects so treatment should be continued as long as necessary while disease is present. This is a significant advantage over many conventional therapies which have cumulative toxicity that limits their use.
GcMAF never stops working and will continue to activate macrophages while treatment is continued, either by GcMAF injections and/or oral administration of Colostrum GcMAF.
Our principle of treatment is, first do no harm.
Second generation GcMAF

Second generation Gc-MAF is produced using a new Patented process which was developed here in Japan by Saisei Mirai in collaboration with researchers from the University of Tokushima who have been studying GcMAF for over 20 years. Our GcMAF is made in our sterile cell processing facility using this new and improved 2nd generation method which is 10-15 times more concentrated and is more active and stable than other GcMAF that is currently available. Importantly, this much higher concentration GcMAF has been clinically demonstrated to be largely free of any side effects in the great majority of patients and is much more stable because it is resistant to oxidation. Only low grade fever or eczema have been observed in about 1 out of 100 patients using GcMAF, but these were short-term effects.